Cargando…

Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model

Pharmacological ascorbate is currently used as an anti-cancer treatment, potentially in combination with radiation therapy, by integrative medicine practitioners. In the acidic, metal-rich tumor environment, ascorbate acts as a pro-oxidant, with a mode of action similar to that of ionizing radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Grasso, Carole, Fabre, Marie-Sophie, Collis, Sarah V., Castro, M. Leticia, Field, Cameron S., Schleich, Nanette, McConnell, Melanie J., Herst, Patries M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266032/
https://www.ncbi.nlm.nih.gov/pubmed/25566497
http://dx.doi.org/10.3389/fonc.2014.00356
_version_ 1782348968157511680
author Grasso, Carole
Fabre, Marie-Sophie
Collis, Sarah V.
Castro, M. Leticia
Field, Cameron S.
Schleich, Nanette
McConnell, Melanie J.
Herst, Patries M.
author_facet Grasso, Carole
Fabre, Marie-Sophie
Collis, Sarah V.
Castro, M. Leticia
Field, Cameron S.
Schleich, Nanette
McConnell, Melanie J.
Herst, Patries M.
author_sort Grasso, Carole
collection PubMed
description Pharmacological ascorbate is currently used as an anti-cancer treatment, potentially in combination with radiation therapy, by integrative medicine practitioners. In the acidic, metal-rich tumor environment, ascorbate acts as a pro-oxidant, with a mode of action similar to that of ionizing radiation; both treatments kill cells predominantly by free radical-mediated DNA damage. The brain tumor, glioblastoma multiforme (GBM), is very resistant to radiation; radiosensitizing GBM cells will improve survival of GBM patients. Here, we demonstrate that a single fraction (6 Gy) of radiation combined with a 1 h exposure to ascorbate (5 mM) sensitized murine glioma GL261 cells to radiation in survival and colony-forming assays in vitro. In addition, we report the effect of a single fraction (4.5 Gy) of whole brain radiation combined with daily intraperitoneal injections of ascorbate (1 mg/kg) in an intracranial GL261 glioma mouse model. Tumor-bearing C57BL/6 mice were divided into four groups: one group received a single dose of 4.5 Gy to the brain 8 days after tumor implantation, a second group received daily intraperitoneal injections of ascorbate (day 8–45) after implantation, a third group received both treatments and a fourth control group received no treatment. While radiation delayed tumor progression, intraperitoneal ascorbate alone had no effect on tumor progression. Tumor progression was faster in tumor-bearing mice treated with radiation and daily ascorbate than in those treated with radiation alone. Histological analysis showed less necrosis in tumors treated with both radiation and ascorbate, consistent with a radio-protective effect of ascorbate in vivo. Discrepancies between our in vitro and in vivo results may be explained by differences in the tumor microenvironment, which determines whether ascorbate remains outside the cell, acting as a pro-oxidant, or whether it enters the cells and acts as an anti-oxidant.
format Online
Article
Text
id pubmed-4266032
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42660322015-01-06 Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model Grasso, Carole Fabre, Marie-Sophie Collis, Sarah V. Castro, M. Leticia Field, Cameron S. Schleich, Nanette McConnell, Melanie J. Herst, Patries M. Front Oncol Oncology Pharmacological ascorbate is currently used as an anti-cancer treatment, potentially in combination with radiation therapy, by integrative medicine practitioners. In the acidic, metal-rich tumor environment, ascorbate acts as a pro-oxidant, with a mode of action similar to that of ionizing radiation; both treatments kill cells predominantly by free radical-mediated DNA damage. The brain tumor, glioblastoma multiforme (GBM), is very resistant to radiation; radiosensitizing GBM cells will improve survival of GBM patients. Here, we demonstrate that a single fraction (6 Gy) of radiation combined with a 1 h exposure to ascorbate (5 mM) sensitized murine glioma GL261 cells to radiation in survival and colony-forming assays in vitro. In addition, we report the effect of a single fraction (4.5 Gy) of whole brain radiation combined with daily intraperitoneal injections of ascorbate (1 mg/kg) in an intracranial GL261 glioma mouse model. Tumor-bearing C57BL/6 mice were divided into four groups: one group received a single dose of 4.5 Gy to the brain 8 days after tumor implantation, a second group received daily intraperitoneal injections of ascorbate (day 8–45) after implantation, a third group received both treatments and a fourth control group received no treatment. While radiation delayed tumor progression, intraperitoneal ascorbate alone had no effect on tumor progression. Tumor progression was faster in tumor-bearing mice treated with radiation and daily ascorbate than in those treated with radiation alone. Histological analysis showed less necrosis in tumors treated with both radiation and ascorbate, consistent with a radio-protective effect of ascorbate in vivo. Discrepancies between our in vitro and in vivo results may be explained by differences in the tumor microenvironment, which determines whether ascorbate remains outside the cell, acting as a pro-oxidant, or whether it enters the cells and acts as an anti-oxidant. Frontiers Media S.A. 2014-12-15 /pmc/articles/PMC4266032/ /pubmed/25566497 http://dx.doi.org/10.3389/fonc.2014.00356 Text en Copyright © 2014 Grasso, Fabre, Collis, Castro, Field, Schleich, McConnell and Herst. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Grasso, Carole
Fabre, Marie-Sophie
Collis, Sarah V.
Castro, M. Leticia
Field, Cameron S.
Schleich, Nanette
McConnell, Melanie J.
Herst, Patries M.
Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title_full Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title_fullStr Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title_full_unstemmed Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title_short Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
title_sort pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266032/
https://www.ncbi.nlm.nih.gov/pubmed/25566497
http://dx.doi.org/10.3389/fonc.2014.00356
work_keys_str_mv AT grassocarole pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT fabremariesophie pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT collissarahv pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT castromleticia pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT fieldcamerons pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT schleichnanette pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT mcconnellmelaniej pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel
AT herstpatriesm pharmacologicaldosesofdailyascorbateprotecttumorsfromradiationdamageafterasingledoseofradiationinanintracranialmousegliomamodel